Spiroindolone KAE609 for Falciparum and Vivax Malaria
Spiroindolone KAE609 for Falciparum and Vivax Malaria
About this item
Full title
Author / Creator
Publisher
Waltham, MA: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Waltham, MA: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
New antimalarial agents are needed, especially given the emergence of artemisinin resistance. In this study from Thailand, treatment with KAE609, the first in the new spiroindolone class, resulted in rapid parasite clearance in patients with
Plasmodium vivax
or
P. falciparum
malaria.
The treatment of
Plasmodium falciparum
malar...
Alternative Titles
Full title
Spiroindolone KAE609 for Falciparum and Vivax Malaria
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4143746
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4143746
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJMoa1315860
